A Comparison of 3 Regimens to Prevent Nevirapine Resistance Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of Nevirapine

Background. Intrapartum single-dose (SD) nevirapine (NVP) reduces perinatal transmission of human immunodeficiency virus (HIV) infection but selects for NVP-resistant virus, which compromises subsequent NVP-based therapy. A 1-week “tail” of lamivudine and zidovudine after SD-NVP decreases the risk o...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Van Dyke, Russell B., Ngo-Giang-Huong, Nicole, Shapiro, David E., Frenkel, Lisa, Britto, Paula, Roongpisuthipong, Anuvat, Beck, Ingrid A., Yuthavisuthi, Praparb, Prommas, Sinart, Puthanakit, Thanyawee, Achalapong, Jullapong, Chotivanich, Nantasak, Rasri, Wirawan, Cressey, Tim R., Maupin, Robert, Mirochnick, Mark, Jourdain, Gonzague
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2012
Gaiak:
HIV/AIDS
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3245730/
https://ncbi.nlm.nih.gov/pubmed/22144539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cir798
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak